This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner you agree to the use of cookies.

Technical Statistical Marketing

Show preferences Accept all

Thursday, January 21st, 2021 - General News

CONTINUUS Pharmaceuticals Secures $69.3 Million Government Contract to Manufacture Critical Medicines in the U.S.

DoD/HHS contract will enable onshore production of three vital medicines to treat critically ill patients, including those with COVID-19. CONTINUUS will build the first GMP-certified end-to-end manufacturing facility using its proprietary technology for the production of small-molecule medicines

Click here for full press release

Share news

Request Information

Phone: (781) 281-0115 Main Office

Email: [email protected]